FUNI (Hypha Labs) Forward PE Ratio: 0.00 (As of Jul. 05, 2026)


What is Hypha Labs Forward PE Ratio?

Hypha Labs FUNI +29.31% Forward PE Ratio is 0.00 as of Jul. 05, 2026. The stock has 2 warning signs investors should review. Among 87 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 1149424.14% on this metric.

Hypha Labs's Forward PE Ratio for today is 0.00.

Hypha Labs's PE Ratio without NRI for today is 9999.00.

Hypha Labs's PE Ratio (TTM) for today is 9999.00.

Hypha Labs  (OTCPK:FUNI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Hypha Labs Forward PE Ratio Related Terms

Hypha Labs Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Hypha Labs's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs Forward PE Ratio Chart

Hypha Labs Annual Data
Trend
Forward PE Ratio

Hypha Labs Quarterly Data
Forward PE Ratio

FUNI vs IVRO, PRPH, IDTA: Forward PE Ratio Comparison

For the Diagnostics & Research subindustry, Hypha Labs's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypha Labs Forward PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Hypha Labs's Forward PE Ratio falls into.


Hypha Labs Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Hypha Labs (FUNI) has a Forward PE Ratio of 0.00 as of Jul. 05, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Hypha Labs and its competitors. According to the industry distribution chart, Hypha Labs ranks #999999 out of 87 companies in the Medical Diagnostics & Research industry.
Is Hypha Labs' Forward PE Ratio too high?
Hypha Labs' current Forward PE Ratio is 0.00. Based on the distribution chart, Hypha Labs ranks #999999 out of 87 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' Forward PE Ratio compare to IVRO and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #999999 out of 87 companies for Forward PE Ratio. This places Hypha Labs in the lower half of its industry. The industry median Forward PE Ratio is 21.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Diagnostics & Research company?
The median Forward PE Ratio among Medical Diagnostics & Research companies is 21.57, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Hypha Labs and its competitors. For the Medical Diagnostics & Research industry, the median Forward PE Ratio is 21.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current Forward PE Ratio of 0.00. The current Forward PE Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Hypha Labs (FUNI), the current Forward PE Ratio is 0.00 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.